Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma
Michael J. Fisher MD
Division of Oncology, Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Search for more papers by this authorMichael Loguidice MD
Departments of Neurology and Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Search for more papers by this authorDavid H. Gutmann MD, PhD
Department of Neurology, Washington University School of Medicine, St Louis, MO
Search for more papers by this authorRobert Listernick MD
Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL
Division of Academic General Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
Search for more papers by this authorRosalie E. Ferner MD
Department of Neurology, Guy's and St. Thomas' NHS Foundation Trust and Institute of Psychiatry, King's College London, London, UK
Search for more papers by this authorNicole J. Ullrich MD, PhD
Department of Neurology, Boston Children's Hospital, Boston, MA
Search for more papers by this authorRoger J. Packer MD
Center for Neuroscience and Behavioral Medicine, Gilbert Neurofibromatosis Institute, Children's National Medical Center, Washington, DC
Search for more papers by this authorUri Tabori MD
Division of Haematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
Search for more papers by this authorRobert O. Hoffman MD
Department of Ophthalmology and Visual Sciences, John Moran Eye Center, University of Utah College of Medicine and Primary Children's Medical Center, Salt Lake City, UT
Search for more papers by this authorSimone L. Ardern-Holmes MD
Children's Hospital at Westmead Clinical School, University of Sydney, and Department of Neurology, Children's Hospital at Westmead, Sydney, Australia
Search for more papers by this authorTrent R. Hummel MD
Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Search for more papers by this authorDarren R. Hargrave MD
Paediatric Oncology Unit, Royal Marsden Hospital, London, UK
Search for more papers by this authorEric Bouffet MD
Division of Haematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
Search for more papers by this authorJoel Charrow MD
Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL
Division of Genetics, Birth Defects, and Metabolism, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
Search for more papers by this authorLarissa T. Bilaniuk MD
Neuroradiology Section, Department of Radiology, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Search for more papers by this authorLaura J. Balcer MD, MSCE
Departments of Neurology and Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Department of Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Search for more papers by this authorLucy D'Agostino McGowan MS
Department of Neurology, Washington University School of Medicine, St Louis, MO
Search for more papers by this authorGrant T. Liu MD
Departments of Neurology and Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Neuro-Ophthalmology Service, Children's Hospital of Philadelphia, Philadelphia, PA
Search for more papers by this authorMichael J. Fisher MD
Division of Oncology, Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Search for more papers by this authorMichael Loguidice MD
Departments of Neurology and Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Search for more papers by this authorDavid H. Gutmann MD, PhD
Department of Neurology, Washington University School of Medicine, St Louis, MO
Search for more papers by this authorRobert Listernick MD
Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL
Division of Academic General Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
Search for more papers by this authorRosalie E. Ferner MD
Department of Neurology, Guy's and St. Thomas' NHS Foundation Trust and Institute of Psychiatry, King's College London, London, UK
Search for more papers by this authorNicole J. Ullrich MD, PhD
Department of Neurology, Boston Children's Hospital, Boston, MA
Search for more papers by this authorRoger J. Packer MD
Center for Neuroscience and Behavioral Medicine, Gilbert Neurofibromatosis Institute, Children's National Medical Center, Washington, DC
Search for more papers by this authorUri Tabori MD
Division of Haematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
Search for more papers by this authorRobert O. Hoffman MD
Department of Ophthalmology and Visual Sciences, John Moran Eye Center, University of Utah College of Medicine and Primary Children's Medical Center, Salt Lake City, UT
Search for more papers by this authorSimone L. Ardern-Holmes MD
Children's Hospital at Westmead Clinical School, University of Sydney, and Department of Neurology, Children's Hospital at Westmead, Sydney, Australia
Search for more papers by this authorTrent R. Hummel MD
Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Search for more papers by this authorDarren R. Hargrave MD
Paediatric Oncology Unit, Royal Marsden Hospital, London, UK
Search for more papers by this authorEric Bouffet MD
Division of Haematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
Search for more papers by this authorJoel Charrow MD
Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL
Division of Genetics, Birth Defects, and Metabolism, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
Search for more papers by this authorLarissa T. Bilaniuk MD
Neuroradiology Section, Department of Radiology, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Search for more papers by this authorLaura J. Balcer MD, MSCE
Departments of Neurology and Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Department of Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Search for more papers by this authorLucy D'Agostino McGowan MS
Department of Neurology, Washington University School of Medicine, St Louis, MO
Search for more papers by this authorGrant T. Liu MD
Departments of Neurology and Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Neuro-Ophthalmology Service, Children's Hospital of Philadelphia, Philadelphia, PA
Search for more papers by this author
References
- 1Diggs-Andrews KA, Brown JA, Gianino SM, et al. Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1. Ann Neurol 2014; 75: 309–316.
- 2Fisher MJ, Loguidice M, Gutmann DH, et al. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol 2012; 14: 790–797.